XML 35 R23.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2025
Revenue Recognition [Abstract]  
Schedule of Disaggregated Revenue
Net Sales by Business
Three Months
2025
2024
MedSurg and Neurotechnology:
Instruments
$730
$667
Endoscopy
867
778
Medical
945
864
Vascular
406
310
Neuro Cranial
563
478
$3,511
$3,097
Orthopaedics:
Knees
$639
$588
Hips
443
393
Trauma and Extremities
945
830
Spinal Implants
166
171
Other
162
164
$2,355
$2,146
Total
$5,866
$5,243
Net Sales by Geography
Three Months 2025
Three Months 2024
United
States
International
United
States
International
MedSurg and Neurotechnology:
Instruments
$587
$143
$532
$135
Endoscopy
710
157
636
142
Medical
802
143
715
149
Vascular
203
203
121
189
Neuro Cranial
465
98
390
88
$2,767
$744
$2,394
$703
Orthopaedics:
Knees
$464
$175
$429
$159
Hips
269
174
251
142
Trauma and Extremities
713
232
611
219
Spinal Implants
118
48
117
54
Other
109
53
112
52
$1,673
$682
$1,520
$626
Total
$4,440
$1,426
$3,914
$1,329
Contract with Customer, Contract Asset, Contract Liability, and Receivable Changes in contract liabilities during the three months 2025 were
as follows:
March 31
2025
Beginning contract liabilities
$978
Revenue recognized from beginning of year contract liabilities
(199)
Net advance consideration received during the period
249
Ending contract liabilities
$1,028